RAPT Therapeutics

RAPT Therapeutics

Phase 2
South San Francisco, United StatesFounded 2015rapt.com

RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives. Join us in our quest.

Founded
2015
Focus
Small Molecules

About

RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases. Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives. Join us in our quest.

Funding History

4

Total raised: $284M

PIPE$125MRA Capital ManagementFeb 15, 2021
IPO$86MUndisclosedSep 19, 2019
Series B$48MKleiner PerkinsDec 15, 2017
Series A$25MKleiner PerkinsOct 15, 2015

Company Info

TypePrivate
Founded2015
LocationSouth San Francisco, United States
StagePhase 2

Contact

SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile